148 related articles for article (PubMed ID: 11175634)
1. Loss of membrane expression of E-cadherin in leukemic erythroblasts.
Acs G; LiVolsi VA
Arch Pathol Lab Med; 2001 Feb; 125(2):198-201. PubMed ID: 11175634
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of hemoglobin A, hemoglobin F, muramidase, and transferrin in erythroid hyperplasia and neoplasia.
Forni M; Meyer PR; Levy NB; Lukes RJ; Taylor CR
Am J Clin Pathol; 1983 Aug; 80(2):145-51. PubMed ID: 6192699
[TBL] [Abstract][Full Text] [Related]
3. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
Mangi MH; Mufti GJ
Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
[TBL] [Abstract][Full Text] [Related]
4. ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens.
Rollins-Raval MA; Fuhrer K; Marafioti T; Roth CG
Am J Clin Pathol; 2012 Jan; 137(1):30-8. PubMed ID: 22180476
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
6. Association between leukemic erythroid progenitors and bone marrow macrophages.
Breton-Gorius J; Vuillet-Gaugler MH; Coulombel L; Guichard J; Teillet F; Vainchenker W
Blood Cells; 1991; 17(1):127-42; discussion 142-6. PubMed ID: 2018849
[TBL] [Abstract][Full Text] [Related]
7. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
Lee WY; Weinberg OK; Pinkus GS
Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
[TBL] [Abstract][Full Text] [Related]
8. The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.
Bühring HJ; Müller T; Herbst R; Cole S; Rappold I; Schuller W; Zhu X; Fritzsch U; Faul C; Armeanu S; Ullrich A; Klein G; Schmidt H
Leukemia; 1996 Jan; 10(1):106-16. PubMed ID: 8558914
[TBL] [Abstract][Full Text] [Related]
9. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
10. A new anti-hemoglobin F antibody against synthetic peptides for the detection of F-cell precursors (F-blasts) in bone marrow.
Choi JW; Kim Y; Fujino M; Ito M
Int J Hematol; 2001 Oct; 74(3):277-80. PubMed ID: 11721963
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin.
Sadahira Y; Kanzaki A; Wada H; Yawata Y
J Clin Pathol; 1999 Dec; 52(12):919-21. PubMed ID: 10711257
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.
Pinkus GS; Pinkus JL
Mod Pathol; 1991 Nov; 4(6):733-41. PubMed ID: 1724087
[TBL] [Abstract][Full Text] [Related]
13. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract][Full Text] [Related]
14. Hemopoietic precursor cells in erythroleukemia.
Suda T; Miura Y; Ozawa K; Mizoguchi H; Takaku F
Stem Cells (1981); 1982; 1(4-5):224-32. PubMed ID: 6959295
[TBL] [Abstract][Full Text] [Related]
15. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues.
Kaumeyer BA; Fidai SS; Thakral B; Wang SA; Arber DA; Cheng JX; Gurbuxani S; Venkataraman G
Am J Clin Pathol; 2022 Aug; 158(2):228-234. PubMed ID: 35311938
[TBL] [Abstract][Full Text] [Related]
16. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
[TBL] [Abstract][Full Text] [Related]
17. Mixed colony formation composed of erythroblasts and myeloblasts by leukemic blast progenitors in patients with erythroleukemia.
Nara N; Tanikawa S; Shiina S
Exp Hematol; 1993 Jan; 21(1):98-102. PubMed ID: 8417964
[TBL] [Abstract][Full Text] [Related]
18. Involvement of E-cadherin in the Development of Erythroid Cells; Subject Heading.
Armeanu S; MÜller CA; Klein G
Hematology; 2000; 5(4):307-316. PubMed ID: 11399629
[TBL] [Abstract][Full Text] [Related]
19. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
Marsee DK; Pinkus GS; Yu H
Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
[TBL] [Abstract][Full Text] [Related]
20. Intercellular contacts between erythroid precursors in the bone marrow in dyserythropoiesis.
Frisch B; Lewis SM; Swan M
Br J Haematol; 1976 Aug; 33(4):469-75. PubMed ID: 1009019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
